JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB110413

Total OXPHOS Rodent WB Antibody Cocktail

5

(18 Reviews)

|

(1603 Publications)

Total OXPHOS Rodent WB Antibody Cocktail ab110413 is an optimized cocktail of high quality antibodies for analyzing relative levels of OXPHOS complexes in rat or mouse mitochondria by western blot.

- Measure the levels of OXPHOS complexes I through V, at the same time, in the same lane of a western blot
- Use 5x less sample and take 5x less time than running separate western blots
- Cited in over 450 publications

View Alternative Names

Complex I-ASHI, NADH-ubiquinone oxidoreductase ASHI subunit, CI-ASHI, NDUFB8

10 Images
Western blot - Total OXPHOS Rodent WB Antibody Cocktail (AB110413)
  • WB

Supplier Data

Western blot - Total OXPHOS Rodent WB Antibody Cocktail (AB110413)

Rat liver mitochondria labeled with ab110413 (MS604). The sample in lane 1 was kept at room temperature, whereas the remaining three samples were heated to 37°C, 50°C, and 100°C, respectively. This blot shows that boiling of samples leads to a decrease in signal due to aggregation of proteins therefore heating samples at or close to boiling is not recommended.

false

Western blot - Total OXPHOS Rodent WB Antibody Cocktail (AB110413)
  • WB

Unknown

Western blot - Total OXPHOS Rodent WB Antibody Cocktail (AB110413)

Isolated mitochondria from heart of human (5 μg - Lane 1), cow (1 ug - Lane 2), rat (10 μg - Lane 3), mouse (10 μg - Lane 4), HepG2 (human liver hepatocellular carcinoma cell line) whole cell lysate (20 μg -Lane 5) labeling CII-30kDa with ab14714 at 5 μg/mL. Secondary antibody is a goat anti-mouse antibody.

Extra bands in the mouse sample (lane 4) are due to the reaction of the IgG-specific goat anti-mouse secondary antibody with residual mouse blood in the heart tissue, as it is very difficult to entirely remove the blood from these small organs.

false

Western blot - Total OXPHOS Rodent WB Antibody Cocktail (AB110413)
  • WB

Unknown

Western blot - Total OXPHOS Rodent WB Antibody Cocktail (AB110413)

Isolated mitochondria from heart of human (5 μg - Lane 1), cow (1 ug - Lane 2), rat (10 μg - Lane 3), mouse (10 μg - Lane 4) labeling CI subunit NDUFB8 with ab110242 at 0.5 ug/ml.

Extra bands in the mouse sample (lane 4) are due to the reaction of the IgG-specific goat anti-mouse secondary antibody with residual mouse blood in the heart tissue, as it is very difficult to entirely remove the blood from these small organs.

false

Western blot - Total OXPHOS Rodent WB Antibody Cocktail (AB110413)
  • WB

Unknown

Western blot - Total OXPHOS Rodent WB Antibody Cocktail (AB110413)

Isolated mitochondria from heart of human (5 μg - Lane 1), cow (1 ug - Lane 2), rat (10 μg - Lane 3), mouse (5 μg - Lane 4) labeling CIV subunit I with ab14705 at 0.5 μg/mL. Secondary antibody is a goat anti-mouse antibody.

Extra bands in the mouse sample (lane 4) are due to the reaction of the IgG-specific goat anti-mouse secondary antibody with residual mouse blood in the heart tissue, as it is very difficult to entirely remove the blood from these small organs.

false

Western blot - Total OXPHOS Rodent WB Antibody Cocktail (AB110413)
  • WB

Unknown

Western blot - Total OXPHOS Rodent WB Antibody Cocktail (AB110413)

Isolated mitochondria from heart of human (10 μg - Lane 1), cow (4 μg - Lane 2), rat (10 μg - Lane 3), mouse (10 μg - Lane 4), HepG2 (human liver hepatocellular carcinoma cell line) whole cell lysate (20 μg -Lane 5) labeling CV alpha subunit with ab14748 at 1 μg/mL

false

Western blot - Total OXPHOS Rodent WB Antibody Cocktail (AB110413)
  • WB

Unknown

Western blot - Total OXPHOS Rodent WB Antibody Cocktail (AB110413)

Human liver tissue lysate, (10 μg - Lane 1) and HepG2 (human liver hepatocellular carcinoma cell line) whole cell lysate (10 μg - Lane 2) labeling CV alpha subunit with ab14748 at 1 μg/mL. Secondary antibody is a goat polyclonal to Mouse IgG - H&L - Pre-Adsorbed (HRP), 1/3000 dilution.

false

Western blot - Total OXPHOS Rodent WB Antibody Cocktail (AB110413)
  • WB

Unknown

Western blot - Total OXPHOS Rodent WB Antibody Cocktail (AB110413)

Human skeletal muscle tissue lysate, (10 μg - Lane 1) and Ramos (human Burkitt's lymphoma cell line) whole cell lysate (10 μg - Lane 2) labeling CIII-Core protein 2 with ab14745 at 5 μg/mL. Secondary antibody is a goat polyclonal to Mouse IgG - H&L - Pre-Adsorbed (HRP), 1/3000 dilution.

false

Western blot - Total OXPHOS Rodent WB Antibody Cocktail (AB110413)
  • WB

AbReview

Western blot - Total OXPHOS Rodent WB Antibody Cocktail (AB110413)

Isolated mitochondria from mice brain (control and Alzheimer's disease (AD)) labeled with ab110413 at 1/1000 dilution in 5% BSA.

This image shows NADH dehydrogenase beta subcomplex subunit 8 of Complex I (NDUFB8), succinate dehydrogenase subunit B of Complex II (SDHB), cytochrome c oxidase subunit 1 of Complex IV (MTCO1), cytochrome b-c1 complex subunit 2 of Complex III (UQCRC2) and ATP synthase subunit alpha of Complex V (ATP5A).

See Abreview

false

This image is courtesy of Aida Adlimoghaddam

Western blot - Total OXPHOS Rodent WB Antibody Cocktail (AB110413)
  • WB

CiteAb

Western blot - Total OXPHOS Rodent WB Antibody Cocktail (AB110413)

Western Blotting using Total OXPHOS Rodent WB Antibody Cocktail, ab110413. Publication image from Karch, J. et al., 2017, Elife, 29148970. Legend direct from paper.

Bax and Bak localize to lysosomes and targeting Bax to lysosomes restores autophagic cell death in DKO MEFs.(A) Western blot analysis of the indicated protein fractions from starved and control WT MEFs for Bax, Bak, Lamp1 and the oxidative phosphorylation mitochondrial proteins UQCRC2 (upper band) and MTCO1 (lower band). (B) Transmission EM image of DKO MEFs treated with an adenovirus for mini SOG-Bax. The yellow arrows show electron dense mini-SOG-Bax within the mitochondrial membranes while the pink arrow heads show electron dense regions within the autolysosomes and lysosomes. Scale bar = 1 μm. (C) DKO MEFs infected with a Dox-inducible adenovirus for Bax containing the lysosomal targeting sequence of Lamp1 on its C-terminus. The infected cells were then treated with or without Dox to induce expression and then subjected to serum starvation to induce autophagic cell death, or treated with 200 nM staurosporine to induce apoptotic cell death. Cell death was determined by plasma membrane rupture. All assays are an average or are representative of three independent experiments. The error bars represent the standard error of the mean. *p<0.05 vs no Dox with students t-test.10.7554/eLife.30543.010Figure 4—source data 1.Raw western gel images for Figure 4A.Raw western gel images for Figure 4A.

false

Western blot - Total OXPHOS Rodent WB Antibody Cocktail (AB110413)
  • WB

CiteAb

Western blot - Total OXPHOS Rodent WB Antibody Cocktail (AB110413)

Western Blotting using Total OXPHOS Rodent WB Antibody Cocktail, ab110413. Publication image from Phielix, E. et al., 2017, Nutr Metab (Lond), 28616059. Legend direct from paper.

Effect of postnatal Concept diet on relative protein expression of 5 oxidative phosphorylation complex (OXPHOS) subunits (a – e) in the retroperitoneal (RP) white adipose tissue (n = 8 for CTRL, n = 7 for Concept and n = 10 for REF group) and (f) total protein and western blot bands of one sample per group, samples came from one blot, but not from adjacent lanes, a picture of the whole blot is added as Additional file 1. Early diet and WSD challenge effects were analyzed separately. Difference between Concept and REF group not tested, as groups were fed different postnatal and adult diets. * : p < 0.05, Concept different from CTRL group; † : p 0.05–0.1 REF different from CTRL group.

false

Key facts

Applications

WB

applications

Target

NDUFB8

target

Reacts with

Mouse, Rat, Cow, Human, Cynomolgus monkey

Form

Liquid

form

Storage buffer

Preservative: 0.02% Sodium azide Constituents: 0.15% HEPES

storage-buffer

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "WB": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p>The antibody cocktail (1.5 mg/mL) should be diluted 250x to a final working concentration of 6.0 µg/mL for Western blotting. We recommend using PBS with 1% milk as the antibody diluent. Store the antibody cocktail at 4°C and the control sample at -80°C. We recommend using a high pH CAPS / PVDF transfer protocol when using this antibody for Western blot. Please contact us for more details.</p>" } } }

Product details

This OXPHOS cocktail ab110413 contains 5 mouse mAbs, one each against CI subunit NDUFB8 (ab110242), CII-30kDa (ab14714), CIII-Core protein 2 (ab14745), CIV subunit I (ab14705) and CV alpha subunit (ab14748) as an optimized premixed cocktail. The kit is suitable for Western Blotting analysis of the relative levels of the 5 OXPHOS complexes in mitochondrial preparations from mouse, rat, human, or bovine sources. The positive control supplied with the cocktail is ab110341.

Altered levels of OXPHOS complex assembly can arise from mutations in individual subunits, mutations in assembly factors for the complex(es), mtDNA depletion or as a result of physiological and or pathological changes e.g. hormone treatment, exercise, diet or oxidative stress.

The mAbs in the cocktail were chosen because they are each against a subunit that is labile when its complex is not assembled. Also, the different subunits are easily resolved in SDS-PAGE (see protocols).

Tips for success

Mouse tissue samples can easily be contaminated with antibodies from the animal's blood. To avoid background bands, use ab110413 with an anti-mouse secondary against native antibodies. We recommend Anti-mouse IgG for IP (HRP) ab131368 which detects native mouse IgG antibodies (subtypes: IgG1, IgG2a, IgG2b, IgG3).

COXI is a highly hydrophobic protein and appears as a broad band at ~35 kDa (not at its true molecular weight at 57 kDa). It is very sensitive to heating. Therefore, the samples, including the positive control, should not be heated over 50°C before loading on the gel.

The antibody cocktail (1.5 mg/mL) should be diluted 250x to a nal working concentration of 6.0 µg/mL for Western blotting.

We recommend using PBS with 1% milk as the antibody diluent, and a high pH CAPS / PVDF transfer protocol. Please contact us for more details.

The Western blot cocktail is supplied at a concentration of 1.5 mg/mL. Store the antibody cocktail at 4°C and the control sample at -80°C.

Related and recommended products

See below other alternative Total OXPHOS WB Antibody Cocktails:
- Total OXPHOS Human WB Antibody Cocktail ab110411
- Total OXPHOS Blue Native WB Antibody Cocktail ab110412

Properties and storage information

Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
Multi
Appropriate long-term storage conditions
Multi

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

MitoProfile® Total OXPHOS Rodent refers to a collection of proteins associated with oxidative phosphorylation (OXPHOS) in rodents. This target includes several key protein complexes involved in the electron transport chain within mitochondria. These complexes specified as OXPHOS Complexes I-V act in conjunction to facilitate ATP production. OXPHOS proteins such as NADH dehydrogenase (complex I) cytochrome c oxidase (complex IV) and ATP synthase (complex V) are detected using antibodies specified in a mitochondrial cocktail or OXPHOS cocktail tailored for Western blots. Mitochondria express these proteins across various tissues including skeletal muscle heart and brain reflecting their essential role in energy metabolism.
Biological function summary

OXPHOS proteins are integral to the production of ATP the primary energy molecule in cells. They form a multi-protein complex that transduces energy by transferring electrons and pumping protons across the inner mitochondrial membrane. The OXPHOS system comprises complexes I to V each playing a specific role within this energy-converting process. This system is important for cellular respiration acting as the powerhouse that drives numerous cellular processes.

Pathways

OXPHOS proteins participate significantly in the mitochondrial electron transport chain and oxidative phosphorylation pathways. The ATP produced through this mechanism contributes to various metabolic pathways and cellular activities. Cytochrome c associated with complex IV plays a pivotal role in apoptotic pathways linking energy metabolism with cell death processes. Other key proteins such as ubiquinone function as electron carriers in the electron transport chain to ensure efficient ATP synthesis.

Impaired OXPHOS function associates with metabolic disorders such as mitochondrial diseases and neurodegenerative conditions like Parkinson's disease. Defects in any of the OXPHOS complexes can lead to insufficient ATP production causing energy deficits in cells and tissues. For example complex I defects can contribute to degenerative disorders linked with lease syndrome through dysregulated energy metabolism. Variations in expression of components within the OXPHOS system such as mutations or deletions can also influence the risk and progression of these diseases.

Product protocols

Target data

Accessory subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I), that is believed not to be involved in catalysis. Complex I functions in the transfer of electrons from NADH to the respiratory chain. The immediate electron acceptor for the enzyme is believed to be ubiquinone.
See full target information NDUFB8

Additional targets

SDHB,UQCRC2,MT-CO1,ATP5F1A

Publications (1603)

Recent publications for all applications. Explore the full list and refine your search

Science advances 11:eadw4153 PubMed41061082

2025

TRAF6 integrates innate immune signals to regulate glucose homeostasis via Parkin-dependent and Parkin-independent mitophagy.

Applications

Unspecified application

Species

Unspecified reactive species

Elena Levi-D'Ancona,Emily M Walker,Jie Zhu,Yamei Deng,Vaibhav Sidarala,Ava M Stendahl,Emma C Reck,Belle A Henry-Kanarek,Anne C Lietzke,Biaoxin Chai,Mabelle B Pasmooij,Dre L Hubers,Venkatesha Basrur,Sankar Ghosh,Linsey Stiles,Alexey I Nesvizhskii,Orian S Shirihai,Scott A Soleimanpour

Cell death & disease 16:680 PubMed41053142

2025

IRE1α translational suppression potentiates STING-dependent chemoresistance in pancreatic cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Yuan Luo,Mengqi Sun,Lei Chang,Zinan He,Xinghang Zhou,Yaming Yuan,Huijuan Sun,Shiqi Luo,Jinyan Huang,Hongkun Wu,Wenjun Liu,Zhangsen Zhou,Yuanhui Mao,Yewei Ji,Tingbo Liang

iScience 28:113449 PubMed41050429

2025

Exploring multiorgan mitochondrial dysfunction in the switch toward progressive MASLD in AMLN mice.

Applications

Unspecified application

Species

Unspecified reactive species

Marica Meroni,Erika Paolini,Miriam Longo,Michele Battistin,Daniele Dondossola,Michela Ripolone,Laura Napoli,Ettore Mosca,Stefania Corti,Paola Dongiovanni

Frontiers in pharmacology 16:1659631 PubMed41001342

2025

Baicalein improves motor dysfunction and cognitive impairment while promoting remyelination in an animal model of multiple sclerosis through the antioxidant mechanism.

Applications

Unspecified application

Species

Unspecified reactive species

Qin Wang,Ziwen Wang,Yutong Li,Qiongzhang Wang,Yanran Chen,Benhao Xu,Haiyun Xu

Nature communications 16:8406 PubMed40998774

2025

Cryo-EM structure of the full-length LGR4-RSPOs complex and a targeting nanobody for anti-obesity therapy.

Applications

Unspecified application

Species

Unspecified reactive species

Zhongyun Zhang,Lu Wang,Huarui Qiao,Haowen Jiang,Shaojue Guo,Yuying Li,Ningning Zhang,Tengjie Geng,Qianqian Cui,Zhongyun Lan,Jie Hong,Weiqiong Gu,Ruixin Liu,Guang Ning,Jia Li,Jiqiu Wang,Yong Geng

Journal of extracellular biology 4:e70087 PubMed40994722

2025

Effect of a 12-Week Endurance Training Program on Circulating Extracellular Vesicle Proteome in Sedentary Adults With Obesity.

Applications

Unspecified application

Species

Unspecified reactive species

Geoffrey Warnier,Sophie van Doorslaer de Ten Ryen,Camille Lannoy,Théo Mahy,Nancy Antoine,Emilien Boyer,Pascal Kienlen-Campard,Kenneth Verboven,Sylvie Copine,Marc Francaux,Louise Deldicque

Regenerative biomaterials 12:rbaf090 PubMed40979828

2025

Plasma-derived mitochondrial transplantation attenuates paraspinal muscle atrophy following spinal surgery.

Applications

Unspecified application

Species

Unspecified reactive species

Ikhyun Lim,Seong-Hoon Kim,Mi Jin Kim,Chang-Koo Yun,Kyunghoon Min,Yong-Soo Choi

Journal of cachexia, sarcopenia and muscle 16:e70047 PubMed40927995

2025

Effects of Combined Exercise Training on Modulating Fine Particulate Matter-Induced Skeletal Muscle Damage in Offspring Gestationally Exposed.

Applications

Unspecified application

Species

Unspecified reactive species

Zilin Wang,Wenduo Liu,Hyun-Jaung Sim,Jeong-Chae Lee,Sung-Ho Kook,Sang Hyun Kim

Nature communications 16:7033 PubMed40908286

2025

Identification of Neuritin 1 as a local metabolic regulator of brown adipose tissue.

Applications

Unspecified application

Species

Unspecified reactive species

Manuela Sánchez-Feutrie,Montserrat Romero,Sónia R Veiga,Núria Borràs-Ferré,Nick Berrow,Martina Ràfols,Noemí Giménez,Andrea Rodgers-Furones,Alba Sabaté-Pérez,Ángela Rodríguez Pérez,Luis Rodrigo Cataldo,Hans Burghardt,David Sebastián,Natàlia Plana,Vanessa Hernández,Laura Isabel Alcaide,Óscar Reina,Maria J Monte,José Juan G Marin,Manuel Palacín,Remy Burcelin,Per Antonson,Jan-Ake Gustafsson,Antonio Zorzano

Frontiers in aging neuroscience 17:1632877 PubMed40900992

2025

Accelerated midlife endocrine and bioenergetic brain aging in APOE4 females.

Applications

Unspecified application

Species

Unspecified reactive species

Tian Wang,Zisu Mao,Yuan Shang,Simona Merlini,Francesca Vitali,Jean-Paul Wiegand,Roberta Diaz Brinton
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com